Trial Profile
Can MRI predict anti-angiogenesis treatment response of hepatocellular carcinoma?
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Apr 2012
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 30 Apr 2012 New trial record